Collaborate Disseminate
Immunotherapy is a promising new form of cancer treatment, but the supercharged immune cells it employs can become exhausted in the fight. Researchers in Japan have found a way to keep them going for longer, by rejuvenating them with stem cells.Continu… Continue reading Stem cell rejuvenation helps immunotherapy fight cancer tirelessly
A new understanding of the way the body teaches immune cells to fight off threats has raised hopes of advanced treatments for autoimmune conditions, and possibly other diseases such as cancer. The discovery centers on an enzyme that plays a key role in… Continue reading Targeting “boot camp” enzyme could fight autoimmune diseases and cancer
Scientists have known for some time that lactic acid can fuel the growth of tumors, but the biological mechanisms behind this relationship have remained unclear. A new study has drilled into the matter and turned up some useful answers around how lacti… Continue reading Targeting lactic acid in tumors may be key to stunting their growth
A pair of new studies have homed in on key biomarkers that could help identify, at the point of initial infection, those most at risk of developing long COVID. The studies suggest a combination of immune biomarkers and acute symptoms can be used to pre… Continue reading How to predict who is most likely to develop long COVID
Researchers at Northwestern University have developed a new kind of nanotherapy to enhance the effectiveness of a potential cure for type 1 diabetes. The innovation packages immunosuppressive drugs into nanoparticles to reduce the likelihood of a body … Continue reading Nanoparticle innovation promises improved type 1 diabetes treatment
As the world grapples with the rapid spread of Omicron, and daily recorded COVID-19 cases reach frightening heights, a handful of new studies are delivering potent reminders that even a mild SARS-CoV-2 infection can lead to the chronic illness that has… Continue reading Long COVID still a threat after mild infections, researchers warn
As the world grapples with the rapid spread of Omicron, and daily recorded COVID-19 cases reach frightening heights, a handful of new studies are delivering potent reminders that even a mild SARS-CoV-2 infection can lead to the chronic illness that has… Continue reading Long COVID still a threat after mild infections, researchers warn
Israel has begun the world’s first roll-out of a fourth COVID-19 vaccine dose. The program is initially focusing on patients with compromised immune systems, while a large study is underway testing the safety and efficacy of a fourth dose in several th… Continue reading Israel begins roll out of 4th COVID vaccine dose
Compelling new preclinical research led by scientists from Yale University has found intranasal vaccination may be much more effective at generating immunity against a number of respiratory viruses compared to more conventional injection-delivered vacc… Continue reading Nasal vaccines may induce broader viral protection than injections
New research led by scientists from the National Institute of Allergy and Infectious Diseases is showing promising preclinical signs for an experimental mRNA vaccine targeting HIV. The sophisticated vaccine was found to generate robust responses in mic… Continue reading Innovative mRNA study closes in on elusive HIV vaccine